Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Blood

• Publication date

  1994-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V84.4.1132.1132PMID 8049429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneity of plasma tissue factor pathway inhibitor.

  1994cited by this paper
• Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor.

  1994cited by this paper
• Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.

  1993cited by this paper
• Studies of factor Xa/phospholipid-induced intravascular coagulation in rabbits. Effects of immunodepletion of tissue factor pathway inhibitor.

  1993cited by this paper
• Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface.

  1992cited by this paper
• The evaluation of complex-dependent alterations in human factor VIIa.

  1992cited by this paper
• Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells.

  1992cited by this paper
• Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.

  1992cited by this paper
• The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity.

  1991cited by this paper
• Tissue factor pathway inhibitor with high anticoagulant activity is increased in post‐heparin plasma and in plasma from cancer patients

  1991cited by this paper
• Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa.

  1991cited by this paper
• Membrane-mediated assembly of the prothrombinase complex.

  1991cited by this paper
• The Extrinsic Pathway Inhibitor: A Regulator of Tissue Factor-Dependent Blood Coagulation

  1991cited by this paper
• The Effect of Flow on Hemostasis and Thrombosis

  1991cited by this paper
• The lipoprotein-associated coagulation inhibitor.

  1991cited by this paper
• Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.

  1991cited by this paper
• Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant.

  1990cited by this paper
• The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

  1990cited by this paper
• Continuous Flow and the Prothrombinase-Catalyzed Activation of Prothrombin

  1990cited by this paper
• Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.

  1990cited by this paper
• Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.

  1990cited by this paper
• Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.

  1990cited by this paper
• Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.

  1989cited by this paper
• Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

  1989cited by this paper
• Human fibroblast tissue factor is inhibited by lipoprotein-associated coagulation inhibitor and placental anticoagulant protein but not by apolipoprotein A-II.

  1989cited by this paper
• Isolation of human blood coagulation alpha-factor Xa by soybean trypsin inhibitor-sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate.

  1989cited by this paper
• Functional Properties of Factor VIIa/Tissue Factor Formed with Purified Tissue Factor and with Tissue Factor Expressed on Cultured Endothelial Cells

  1989cited by this paper
• Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor.

  1988cited by this paper
• Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

  1988cited by this paper
• Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection.

  1988cited by this paper
• The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

  1988cited by this paper
• Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor

  1988cited by this paper
• Flow as a regulator of the activation of factor X by tissue factor.

  1988cited by this paper
• A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions.

  1987cited by this paper
• Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor.

  1985cited by this paper
• The haemostatic plug in haemophilia A: a morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A

  1984cited by this paper
• Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.

  1984cited by this paper
• A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components.

  1983cited by this paper
• Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.

  1982cited by this paper
• Purification and characterization of human coagulation factor V.

  1981cited by this paper
• Isolation and characterization of human factor VII. Activation of factor VII by factor Xa.

  1981cited by this paper
• Properties of the factor Xa binding site on human platelets.

  1978cited by this paper
• Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

  1977cited by this paper
• Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII.

  1975cited by this paper
• Isolation and characterization of bovine factor IX (Christmas factor).

  1973cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper

• Temporal Roles of Platelet and Coagulation Pathways in Collagen- and Tissue Factor-Induced Thrombus Formation

  2021cites this paper
• Venous Thrombosis in Acquired Hemophilia: The Complex Management of Competing Pathologies

  2019cites this paper
• Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength

  2018cites this paper
• A mathematical model for in vitro coagulation of blood: role of platelet count and inhibition

  2017cites this paper
• A mathematical model for in vitro coagulation of blood: role of platelet count and inhibition

  2017cites this paper
• The effects of crystalloid solutions on the human blood coagulation system

  2016cites this paper
• Human coagulation factor VIII domain-specific recombinant polypeptide expression

  2015influential citation
• Diabetes worsening of hepatitis C cirrhosis: are alterations in monocytic tissue factor (CD 142) is the cause?

  2013cites this paper
• Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia

  2012cites this paper
• Factor seven activating protease (FSAP): does it activate factor VII?

  2012cites this paper
• Endogenous anticoagulants.

  2012cites this paper
• The effect of physiologically relevant dynamic shear stress on platelet and endothelial cell activation.

  2011cites this paper
• Fluid Shear Stress Alters the Hemostatic Properties of Endothelial Outgrowth Cells

  2011cites this paper
• Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidic model of vessel injury.

  2011cites this paper
• Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms

  2011cites this paper
• The potential role of endothelial progenitor cells for therapeutic angiogenesis.

  2011cites this paper
• Inflammation and lifestyle in cardiovascular medicine

  2010cites this paper
• Cloning and comparison of factor X from rhesus monkey (Macaca mulatta).

  2009cites this paper
• Protein S as Cofactor for TFPI

  2009cites this paper
• Characterization of porcine factor VII, X and comparison with human factor VII, X.

  2009cites this paper
• Tissue factor: past, present, and future.

  2009cites this paper
• Regulation de l'activite du facteur tissulaire par la proteine s et inhibiteur de la voie du facteur tissulaire

  2006cites this paper
• Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.

  2006cites this paper
• Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow model.

  2006cites this paper
• ORJNAL ARATIRMA / ORIGINAL RESEARCH. Kömür Madeni çilerinde Plazma Antikoagülan Protein Düzeyleri ve Trombin Zamaninin Deerlendirilmesi

  2004cites this paper
• Tissue factor and tissue factor pathway inhibitor

  2004cites this paper
• Linking Biochemistry, Vascular Biology, and Clinical Events in Acute Coronary Syndromes

  2003cites this paper
• Comparative Effects of Unfractionated Heparin and Low Molecular Weight Heparin on Vascular Endothelial Cell Tissue Factor Pathway Inhibitor Release: A Model for Assessing Intrinsic Thromboresistance

  2002cites this paper
• Simultaneous Deep Venous Thrombosis and Acquired Factor VIII Inhibitor

  2002cites this paper
• Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases

  2001cites this paper
• Disordered regulation of coagulation and platelet activation in xenotransplantation

  2000cites this paper
• The Regulation of the Factor VII-Dependent Coagulation Pathway: Rationale for the Effectiveness of Recombinant Factor VIIa in Refractory Bleeding Disorders

  2000cites this paper
• Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.

  2000cites this paper
• Anomalies de la voie du facteur tissulaire en pathologie thrombotique veineuse

  2000cites this paper
• Platelet Surface Physiology and Its Importance in Pharmacotherapy Design and Development: The Adenosine Diphosphate Receptor Antagonists

  2000cites this paper
• Mann for the treatment of hemophilia A by factor VIIa Inhibition of thrombin generation by the zymogen factor VII : implications

  2000cites this paper
• Acute Release of Tissue Factor Pathway Inhibitor after In Vivo Thrombin Generation in Baboons

  1999cites this paper
• Factors in Xenograft Rejection

  1999cites this paper
• Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.

  1999cites this paper
• Linking Biochemical, Pathologic, and Clinical Events in Acute Coronary Syndromes

  1999cites this paper
• Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1.

  1999cites this paper
• Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs.

  1999cites this paper
• Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders.

  1998cites this paper
• Detection of the Three Kunitz-Type Single Domains of Membrane-Bound Tissue Factor Pathway Inhibitor (TFPI) by Flow Cytometry

  1997cites this paper
• Anticoagulant Properties of the Vascular Endothelium

  1997cites this paper
• Tissue Factor Pathway Inhibitor: Potential Therapeutic Applications

  1997cites this paper
• Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium.

  1997cites this paper
• Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin.

  1996cites this paper
• Cell biology of tissue factor, the principal initiator of blood coagulation.

  1996cites this paper
• The human pharmacology of thrombin inhibition.

  1996cites this paper
• Tissue factor pathway inhibitor protects the ischemic spinal cord.

  1996cites this paper
• Tissue factor pathway inhibitor and the current concept of blood coagulation

  1995cites this paper
• Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model.

  1995cites this paper
• Inhibition of Factor X Activation at Extracellular Matrix of Fibroblasts During Flow Conditions: A Comparison Between Tissue Factor Pathway Inhibitor and Inactive Factor VIIa

  1995cites this paper
• Increased prothrombin activation in protein S-deficient plasma under flow conditions on endothelial cell matrix: an independent anticoagulant function of protein S in plasma.

  1995cites this paper
• Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.

  1995cites this paper